Stada

Founded in 1895 and headquartered in Bad Vilbel, Germany, Stada has established itself as a significant player in the pharmaceutical industry, with a focus on two main business categories: Generics and Branded Products. In the Generics category, the company specializes in the manufacturing of non-patented pharmaceuticals that mirror branded drugs in essential attributes such as dose, strength, route of administration, quality, performance, and intended use. The Branded Products segment includes a variety of over-the-counter (OTC) medications and healthcare products marketed under proprietary trademarks. Stada's portfolio comprises several key brands that have grown in both reputation and reach. Grippostad is renowned for its efficacy in treating cold and flu symptoms, while Ladival offers a range of skin care solutions including sunscreens. For those suffering from musculoskeletal pain, Mobilat delivers targeted relief, and Snup is the go-to brand for nasal decongestants. With a global operational footprint, Stada's products and services are particularly prominent in Europe, having a strong market presence in Germany, Russia, Italy, Spain, and the United Kingdom. The company's reach extends beyond these countries, serving various other markets across Europe and selected international landscapes, marking its international identity in the pharmaceutical domain. (Powered by AI)